The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In contrast with the aforementioned study of GLP-1 RA, we found no effect on epicardial fat volume.
“In contrast with the aforementioned study of GLP-1 RA,21 we found no effect on epicardial fat volume”
From Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure (2025) · cites this paper as [21]
A recent randomized study using noncontrast computed tomography in the STOP trial showed semaglutide reduced EAT by 19.3 mm3 as compared with placebo in 115 diabetic patients with known coronary artery disease.
“A recent randomized study using noncontrast computed tomography in a prespecified secondary analysis of the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) trial, the GLP-1 RA semaglutide was shown to reduce EAT by 19.3 mm3 as compared with placebo in 115 diabetic patients with known coronary artery disease.21”
From Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure (2025) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dozio, E., Vianello, E., Malavazos, A. E., Tacchini, L., Schmitz, G., Iacobellis, G., & Corsi Romanelli, M. M. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.039 · Cited by 118
Flagged first, then by citations
Research works printed but not linked: 4
- Goeller, 2018, Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects, J Cardiovasc Comput Tomogr, 12, 67, 10.1016/j.jcct.2017.11.007 · DOI
- Eisenberg, 2020, Deep learning-based quantification of epicardial adipose tissue volume and attenuation predicts major adverse cardiovascular events in asymptomatic subjects, Circ Imaging, 13
- Hamal, 2020, Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial, Coron Artery Dis, 31, 306, 10.1097/MCA.0000000000000830 · DOI
- Iacobellis, 2020, Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity, J Endocr Soc, 4
Cited by
Sorted by citations
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
Kramer, C. M., Borlaug, B. A., Zile, M. R., Ruff, D., DiMaria, J. M., Menon, V., Ou, Y., Zarante, A. M., Hurt, K. C., Murakami, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.11.001 · Cited by 200
Metadata
- Authors
- Manubolu, V. S., Lakshmanan, S., Kinninger, A., Ahmad, K., Susarla, S., Seok, H. J., Hamal, S., Dahal, S., Roy, S. K., & Budoff, M. J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2024-08
- Volume
- 84
- Issue
- 9
- Pages
- 865-867
- ISSN
- 0735-1097
- Cited by
- 41
- References
- 1
- Language
- en
- Licence
- Funders
- New Netherland Institute
- National Institutes of Health
- Novo Nordisk AS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
